LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Jhita, Tracey; Petrou, Stavros; Gumber, Anil; Szczepura, Ala; Raymond, Neil T; Bellary, Srikanth (2014)
Publisher: BioMed Central
Journal: Health and Quality of Life Outcomes
Languages: English
Types: Article
Subjects: RC, South Asian, Type 2 diabetes, EQ-5D, Ethnicity, GN, Health related quality of life, Research

Background: The objective of this study was to investigate the association between ethnicity and health related quality of life (HRQoL) in patients with type 2 diabetes.

\ud

Methods: The EuroQol EQ-5D measure was administered to 1,978 patients with type 2 diabetes in the UK Asian\ud Diabetes Study (UKADS): 1,486 of south Asian origin (Indian, Pakistani, Bangladeshi or other south Asian) and 492 of white European origin. Multivariate regression using ordinary least square (OLS), Tobit, fractional logit and Censored Least Absolutes Deviations estimators was used to estimate the impact of ethnicity on both visual analogue scale (VAS) and utility scores for the EuroQol EQ-5D.

\ud

Results: Mean EQ-5D VAS and utility scores were lower among south Asians with diabetes compared to the white\ud European population; the unadjusted effect on the mean EQ-5D VAS score was −7.82 (Standard error [SE] = 1.06,\ud p < 0.01) and on the EQ-5D utility score was −0.06 (SE = 0.02, p < 0.01) (OLS estimator). After controlling for\ud socio-demographic and clinical confounders, the adjusted effect on the EQ-5D VAS score was −9.35 (SE = 2.46,\ud p < 0.01) and on the EQ-5D utility score was 0.06 (SE = 0.04), although the latter was not statistically significant.

\ud

Conclusions: There was a large and statistically significant association between south Asian ethnicity and lower EQ-5D VAS scores. In contrast, there was no significant difference in EQ-5D utility scores between the south Asian and white European sub-groups. Further research is needed to explain the differences in effects on subjective EQ-5D VAS scores and population-weighted EQ-5D utility scores in this context.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Diabetes UK: Diabetes in the UK 2010 - Key statistics on Diabetes; 2010 [http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_UK_2010. pdf] Diabetes UK. What is diabetes? 2011. [http://www.diabetes.org.uk/ Guide-to-diabetes/Introduction-to-diabetes/What_is_diabetes/]
    • 2. Greenhalgh PM: Diabetes in British south Asians: nature, nurture, and culture. Diabet Med 1997, 14:10-18.
    • 3. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A, Kumar S, Barnett AH, UKADS Study Group: Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet 2008, 371:1769-1776.
    • 4. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14(Suppl 5):S1-85.
    • 5. Wändell P: Foreign- and Swedish-born diabetic patients - medical situation and quality of life. Scand J Prim Health Care 1999, 17:158-163.
    • 6. Wee H, Li S, Cheung Y, Fong K, Thumboo J: The influence of ethnicity on health-related quality of life in diabetes mellitus. J Diabetes Complications 2006, 20:170-178.
    • 7. Thommasen HV, Berkowitz J, Thommasen AT, Michalos AC: Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural & Remote Health 2005, 5:1-18.
    • 8. Two Feathers JT, Kieffer EC, Palmisano G, Anderson M, Sinco B, Janz N, Heisler M, Spencer M, Guzman R, Thompson J, Wisdom K, James SA: Racial and ethnic approaches to community health (reach) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health 2005, 95:1552-1560.
    • 9. Quandt SA, Graham CN, Bell RA, Snively BM, Golden SL, Stafford JM, Arcury TA: Ethnic disparities in health-related quality of life among older rural adults with diabetes. Ethn Dis 2007, 17:471-476.
    • 10. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK: Functional impairment in Mexican Americans and non-Hispanic whites with diabetes. J Clin Epidemiol 1990, 43:319-327.
    • 11. Hill-Briggs F, Gary T, Hill M, Bone L, Brancati F: Health-related quality of life in urban African Americans with type 2 diabetes. J Gen Intern Med 2002, 17:412-419.
    • 12. Caldwell EM, Baxter J, Mitchell CM, Shetterly SM, Hamman RF: The association of non-insulin-dependent diabetes mellitus with perceived quality of life in a biethnic population: the San Luis Valley diabetes study. Am J Public Health 1998, 88:1225-1229.
    • 13. Sedgwick J, Pearce AJ, Gulliford MC: Evaluation of equity in diabetes health care in relation to African and Caribbean ethnicity. Ethn Health 2003, 8:121-133.
    • 14. Lubetkin E, Jia H, Franks P, Gold M: Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Qual Life Res 2005, 14:2187-2196.
    • 15. Brooks R: EuroQoL: the current state of play. Health Policy 1996, 37:53-72.
    • 16. Dolan P, Gudex C, Kind P, Williams A: A social tariff for EuroQol: Results from a UK general population survey. University of York: York, Centre for Health Economics; 1995:1-19.
    • 17. NICE: Guide to the methods of technology Appraisal, 2008, section 5.4.1 -5.4.4. ; 2008 [http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf]
    • 18. Papke LE, Wooldridge JM: Econometric methods for fractional response variables with an application to 401 (K) plan participation rates. J Appl Econ 1996, 11:619-632.
    • 19. Powell JL: Least absolute deviations estimation for the censored regression model. J Econom 1984, 25(3):303-325.
    • 20. Wooldridge JM: Introductory Econometrics: A Modern Approach. 4th edition. Canada: South-Western Cengage Learning; 2009:68-105. 444-471.
    • 21. Clarke P, Gray A, Holman R: Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002, 22:340-349.
    • 22. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A: Measuring and Valuing Health Benefits for Economic Evaluation. Oxford, UK: Oxford University Press; 2007.
    • 23. Carstairs V, Morris R: Deprivation and health in Scotland. Health Bull (Edinb) 1990, 48:162-175.
    • 24. Bellary S, O'Hare P, Raymond NT, Mughal S, Hanif WM, Jones A, Kumar S, Barnett AH: Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian diabetes study - effect of ethnicity on risk. Curr Med Res Opin 2010, 26:1873-1879.
    • 25. WHO: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
    • 26. NHS: Statistics on Smoking. England; 2010 [http://www.hscic.gov.uk/ catalogue/PUB00684/smok-eng-2010-rep.pdf]
    • 27. NHS: 2010. Statistics on Alcohol. England; 2010 [http://www.hscic.gov.uk/ catalogue/PUB00135/alco-eng-2010-rep.pdf]
    • 28. Dolan P, Gudex C, Kind P, Williams A: The time trade-off method: results from a general population study. Health Econ 1996, 5:141-154.
    • 29. Thoolen B, Ridder DD, Bensing J, Gorter K, Rutten G: Who participates in diabetes self-management interventions?: issues of recruitment and retainment. Diabetes Educ 2007, 33:465-474.
    • 30. Dakin H: Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes 2013, 11:151.
    • 31. Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O'Reilly D: Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health 2010, 13(4):487-494.
    • 32. Pullenayegum EM, Tarride JE, Xie F, O'Reilly D: Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making 2011, 31(6):790-799.
    • 33. Dakin H, Gray A, Murray D: Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score. Qual Life Res 2013, 22(3):683-694.
    • 34. Hernández AM, Wailoo AJ, Ara R: Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health 2012, 15:550-561.
  • No related research data.
  • No similar publications.